Press Releases :: VolitionRx Ltd (VNRX)

Mar 30, 2022 4:10 pm EDT

VolitionRx Limited Announces Full Fiscal Year 2021 Financial Results and Business Update

Mar 29, 2022 8:00 am EDT

Volition Signs Exclusive $28 million License and Supply Agreement with Heska Corporation to Distribute Nu.Q® Vet Cancer Screening Test at the Point of Care

Mar 28, 2022 4:25 pm EDT

VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings Conference Call and Business Update

Jan 20, 2022 8:30 am EST

Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas

Dec 16, 2021 8:00 am EST

Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia

Nov 10, 2021 4:10 pm EST

VolitionRx Limited Announces Third Quarter 2021 Financial Results and Business Update

Nov 8, 2021 8:30 am EST

VolitionRx Limited Schedules Third Quarter 2021 Earnings Conference Call and Business Update

Nov 4, 2021 8:33 am EDT

Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference

Aug 11, 2021 4:10 pm EDT

VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update

Aug 4, 2021 8:15 am EDT

VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business Update

rss_feed News RSS